A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Rituximab (Primary) ; Ciclosporin; Prednisone; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 17 Dec 2013 Planned End Date changed from 1 May 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 11 Jul 2012 Planned end date changed from 1 Jun 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 11 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.